Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Analyst Coverage
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
Apr 29, 2019 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-19-013503.pdf
0001564590-19-013503.rtf
0001564590-19-013503.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Apr 16, 2020 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-20-016974.pdf
0001564590-20-016974.rtf
0001564590-20-016974.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Apr 23, 2021 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-21-020241.pdf
0001564590-21-020241.rtf
0001564590-21-020241.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 25, 2022 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-22-011742.pdf
0001564590-22-011742.rtf
0001564590-22-011742.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 06, 2021 20-F/A

Amendment to a previously filed 20-F

Annual Filings
View HTML
0001193125-21-238541.pdf
0001193125-21-238541.rtf
0001193125-21-238541.xls
May 08, 2018 424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
0001193125-18-154838.pdf
0001193125-18-154838.rtf
0001193125-18-154838.xls
May 08, 2018 424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
0001193125-18-155131.pdf
0001193125-18-155131.rtf
0001193125-18-155131.xls
Dec 02, 2019 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
0001193125-19-304462.pdf
0001193125-19-304462.rtf
0001193125-19-304462.xls
Dec 04, 2019 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
0001193125-19-306309.pdf
0001193125-19-306309.rtf
0001193125-19-306309.xls
Oct 09, 2020 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

Registration Statements
View HTML
0001193125-20-267301.pdf
0001193125-20-267301.rtf
0001193125-20-267301.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com